Physician profile
Gerald Rodts
NPI 1811944861
$1,170,479.32
in general payments reported to CMS, 2019-2025
7 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274K · 2020: $237K · 2021: $251K · 2022: $264K · 2023: $131K · 2024: $14K · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $116K · Consulting Fee: $24K · Travel and Lodging: $4,109 · Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $116,229.00 |
| Consulting Fee | $24,090.00 |
| Travel and Lodging | $4,108.74 |
| Food and Beverage | $857.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $579,707.00 | 2021-2023 | Zevo Anterior Cervical Plate System |
| Medtronic USA, INC. | $451,478.77 | 2019-2020 | |
| Globus Medical, INC. | $96,180.98 | 2019-2025 | Continental |
| Orthofix Medical, INC. | $28,826.12 | 2023-2025 | Mariner, Miscellaneous |
| Seaspine Orthopedics Corporation | $14,076.17 | 2021-2022 | |
| Stryker Corporation | $133.06 | 2023-2025 | Mako, Everest Spinal System, Tritanium |
| Spine Wave, INC. | $77.22 | 2024 | Spinal Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Rodts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.